[{"NetIncomeLoss_1_Q1_USD":31078000.0,"Depreciation_1_Q1_USD":7400000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-1106000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-13295000.0,"InventoryFinishedGoods_0_Q1_USD":39287000.0,"InterestPaidNet_1_Q1_USD":4689000.0,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":3564000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":213119000.0,"PurchaseObligation_0_Q1_USD":301500000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q1_USD":35000.0,"PaidInKindInterest_1_Q1_USD":2585000.0,"EquityMethodInvestmentUnderlyingEquityInNetAssets_0_Q1_USD":2479000.0,"AccountsAndOtherReceivablesNetCurrent_0_Q1_USD":351000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":640853200.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q1_USD":1000000000.0,"ConvertibleLongTermNotesPayable_0_Q1_USD":224782000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":300000.0,"LiabilitiesNoncurrent_0_Q1_USD":419131000.0,"LineOfCredit_0_Q1_USD":16093000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":3770000.0,"GoodwillImpairmentLoss_1_Q1_USD":0.0,"InventoryValuationReserves_0_Q1_USD":4897000.0,"FinanceLeaseInterestExpense_1_Q1_USD":600000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":308000.0,"AccountsReceivableGrossCurrent_0_Q1_USD":322940000.0,"TreasuryStockShares_0_Q1_shares":549907.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":921000.0,"OtherInventorySupplies_0_Q1_USD":114042000.0,"FinanceLeaseInterestPaymentOnLiability_1_Q1_USD":33000.0,"ContractWithCustomerLiability_0_Q1_USD":15588000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":112286000.0,"OtherLiabilitiesAndDeferredRevenueNoncurrent_0_Q1_USD":16759000.0,"LongTermDebt_0_Q1_USD":246517000.0,"AssetsCurrent_0_Q1_USD":599049000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":5587000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-4440000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-9070000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":2506000.0,"TreasuryStockValue_0_Q1_USD":1791000.0,"OperatingLeaseLiability_0_Q1_USD":42699000.0,"GainLossOnInvestments_1_Q1_USD":-43000.0,"CommonStockValue_0_Q1_USD":6707000.0,"NumberOfReportableSegments_1_Q1_segment":2.0,"IncomeTaxExpenseBenefit_1_Q1_USD":560000.0,"AccountsReceivableNetCurrent_0_Q1_USD":320462000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-927000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-27126000.0,"AssetsFairValueDisclosure_0_Q1_USD":8933000.0,"ProceedsFromIssuanceOrSaleOfEquity_1_Q1_USD":308000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":525000.0,"InventoryWriteDown_1_Q1_USD":3100000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-447000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":365074000.0,"InventoryRawMaterials_0_Q1_USD":5966000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":51294000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":19315000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":7492000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":-201000.0,"FinanceLeaseLiability_0_Q1_USD":4793000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":479713000.0,"ProceedsFromLinesOfCredit_1_Q1_USD":472213000.0,"Liabilities_0_Q1_USD":823061000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":8079000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":32394000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":89503000.0,"OtherAssetsNoncurrent_0_Q1_USD":9745000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":12577000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":62231000.0,"Supplies_0_Q1_USD":13628000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":46428000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":1525000.0,"IncreaseDecreaseInInventories_1_Q1_USD":27912000.0,"OtherAssetsCurrent_0_Q1_USD":5063000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q1_USD":4999000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":-957000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-7192000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":19989000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":22008000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-790000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":7471000.0,"IncomeTaxesPaidNet_1_Q1_USD":1470000.0,"NonoperatingIncomeExpense_1_Q1_USD":-6756000.0,"AccountsPayableCurrent_0_Q1_USD":162690000.0,"LiabilitiesCurrent_0_Q1_USD":403930000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":10666000.0,"PaymentsToAcquireProductiveAssets_1_Q1_USD":9245000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":0.0,"InventoryWorkInProcess_0_Q1_USD":4706000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":89503000.0,"GainLossOnDispositionOfAssets1_1_Q1_USD":3039000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2647000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":60000.0,"Goodwill_0_Q1_USD":676162000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.043,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-9070000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-43000.0,"AmortizationOfFinancingCosts_1_Q1_USD":222000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":26037000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":790000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":29980000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":69477000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":139069000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":3564000.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q1_USD":105795000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":135244000.0,"PrepaidInsurance_0_Q1_USD":1458000.0,"LinesOfCreditCurrent_0_Q1_USD":17816000.0,"OperatingLeasePayments_1_Q1_USD":4245000.0,"LongTermDebtNoncurrent_0_Q1_USD":3325000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":456309000.0,"AdditionalPaidInCapital_0_Q1_USD":3155648000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":113000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-1255000.0,"EquitySecuritiesFvNiRealizedGainLoss_1_Q1_USD":2981000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.057,"DerivativeFairValueOfDerivativeAsset_0_Q1_USD":96000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":571000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":1696514000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":206000.0,"ContractWithCustomerLiabilityRevenueRecognized_14_Q1_USD":0.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1_Q1_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":31681000.0,"OperatingIncomeLoss_1_Q1_USD":38437000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":545165000.0,"CommonStockSharesAuthorized_0_Q1_shares":1000000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1415000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":3714000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":8595000.0,"InventoryNet_0_Q1_USD":159104000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"ShareBasedCompensation_1_Q1_USD":2647000.0,"GainLossOnSaleOfInvestments_1_Q1_USD":2780000.0,"Assets_0_Q1_USD":2519575000.0,"CommonStockSharesIssued_0_Q1_shares":670703076.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1869000.0,"EquitySecuritiesFvNi_0_Q1_USD":8837000.0,"GainLossOnDerivativeInstrumentsNetPretax_1_Q1_USD":-439000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":38631000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q1_USD":28000000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":15031000.0,"OperatingLeaseCost_1_Q1_USD":4500000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":35238000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":17292000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1450755000.0,"VariableLeaseCost_1_Q1_USD":700000.0,"LongTermInvestments_0_Q1_USD":10410000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":2478000.0,"EquityMethodInvestmentQuotedMarketValue_0_Q1_USD":7600000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-1033000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":557000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":26711000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":0.05,"OperatingExpenses_1_Q1_USD":506728000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":10305000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":4793000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2600000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2519575000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":2287000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":4790000.0,"Ticker":"OPK","CIK":"944809","name":"OPKO HEALTH, INC.","OfficialName":"OPKO Health Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2187471532.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20210428"}]